课题基金 / 基金详情

HRQOL-enhancing ostomy self-management intervention for CRC survivors

HRQOL-enhancing ostomy self-management intervention for CRC survivors
提高 CRC 幸存者 HRQOL 的造口自我管理干预措施
批准号:
7917405
负责人:
Robert Scott Krouse
金额:
$12.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-13 至 2014-01-31

项目摘要

项目成果

Robert Scott Krouse的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):我们的目标与NCI的战略目标一致,即改善癌症患者、幸存者及其家属的生活质量,以及与医学研究所的慢性护理模式一致,该模式旨在通过计划、经过验证的策略和管理,将目前的反应性医疗保健系统转变为使患者尽可能健康的医疗保健系统。结直肠癌(CRC)和其他需要接受肠造口术的癌症患者在应对其病情时面临许多障碍,其中最重要的是医疗保健往往不能满足他们对有效培训和自我保健信息、临床管理或心理支持的需求。造口者及其家属必须参与造口管理,做出行为改变,并适应这种情况的后果。这可能包括一个家庭成员或朋友成为主要的看护人。为确保最佳的HRQOL和功能,患者及其选择的护理人员的准备是必要的。我们的主要目标是通过三家社区医院招募一组社区癌症患者,以测试慢性护理造口自我管理(CCOSM)计划的可行性、可接受性和可理解性,该计划由一名认证造口护理护士(COCN)和经过培训的同行造口“伙伴”协助。次要目标是:a)评估每次会议的患者和护理人员评价的有效性;B)在每个疗程结束时获得干预者对每个参与者的有效性的估计;C)使用离职面谈来评估项目的可接受性和满意度;d)评估造口特异性HRQOL评分与激活(PAM)量表评分和应对方式(Ways)模式和评分之间的关系和相关性;e)衡量CCOSM项目成本和患者/家属参加项目的自付费用;f)为更大规模的干预研究开发基础设施和策略。我们的长期目标是启动一项针对结直肠癌和其他癌症幸存者的随机、对照、多地点慢性护理造口自我管理计划干预研究。本研究的最终目标是为结直肠癌和其他有新肠造口的癌症患者开发一个有效的、令人满意的、可出口的护理系统,使他们能够保持最大的HRQOL和功能,采用循证的、临床的、具有成本效益的、可持续的造口管理计划,包括“伙伴”同伴,以及患者和家庭的教育和支持。重要的是,我们将为更大的干预研究创建基础设施。公共卫生相关性:本研究的最终目标是开发一个有效的、令人满意的、易于使用的系统,为结直肠癌和其他癌症患者提供新的粪便肠造口,使他们能够保持最大的健康相关的生活质量和功能,使用循证的、临床的、具有成本效益的、可持续的造口管理计划,包括“伙伴”同伴,以及患者和家庭的教育和支持。我们的目标遵循国家癌症研究所的战略目标,即改善癌症患者,幸存者及其家属的生活质量,以及医学研究所的慢性护理模式,该模式旨在通过计划,经过验证的策略和管理将目前的反应性医疗保健系统转变为使患者尽可能健康的系统。
英文摘要
DESCRIPTION (provided by applicant): Our aims are consonant with the NCI's strategic objective to improve the quality of life for cancer patients, survivors, and their families, as well as with the Institute of Medicine's Chronic Care Model, which seeks to transform what is currently a reactive health care system into one that keeps patients as healthy as possible through planning, proven strategies and management. Colorectal cancer (CRC) and other cancer patients who are required to undergo intestinal ostomies, face many obstacles in coping with their condition, not least of which is medical care that often does not meet their needs for effective training and information regarding self-care, clinical management, or psychological support. Ostomates and their families must engage in ostomy management, make behavioral changes, and adjust to the consequences of this condition. This may include a family member or friend becoming the principal caretaker. Preparation of the patient and their chosen caregiver is requisite to assure optimal HRQOL and functioning. Our primary aim is to recruit a group of community cancer patients through three community hospitals to test the feasibility, acceptability, and comprehensibility of a Chronic Care Ostomy Self-Management (CCOSM) Program facilitated by a certified ostomy care nurse (COCN) and trained peer-ostomate "buddies". Secondary aims are to: a) evaluate the patient- and caregiver-rated effectiveness of each session; b) obtain interventionists' estimates of the effectiveness of each session for each participant at the end of the sessions; c) use exit interviews to evaluate the acceptability of, and satisfaction with, the program; d) evaluate relationships and correlations between ostomy-specific HRQOL scores and both Activation (PAM) scale scores and Ways of Coping (WAYS) patterns and scores; e) measure CCOSM program costs and patient/family out of pocket expenses to participate in the program; and f) develop the infrastructure and strategy for a larger intervention study. Our long term objectives are to initiate a randomized, controlled, multi-site Chronic Care Ostomy Self-Management Program intervention study for CRC and other cancer survivors. The ultimate goal of this research is to develop an effective, satisfying and exportable system of care for CRC and other cancer patients with new intestinal stomas so that they can maintain their maximum HRQOL and functioning, using an evidence-based, clinically and cost-effective, sustainable ostomy-management program, incorporating "buddy" peers, along with patient and family education and support. Importantly, we will create the infrastructure for a larger intervention study. PUBLIC HEALTH RELEVANCE: The ultimate goal of this research is to develop an effective, satisfying and easily usable system of care for colorectal and other cancer patients with new fecal intestinal stomas so that they can maintain their maximum health-related quality of life and functioning, using an evidence-based, clinically and cost-effective, sustainable ostomy-management program, incorporating "buddy" peers, along with patient and family education and support. Our aims follow the National Cancer Institute's strategic objective to improve the quality of life for cancer patients, survivors, and their families, as well as with the Institute of Medicine's Chronic Care Model, which seeks to transform what is currently a reactive health care system into one that keeps patients as healthy as possible through planning, proven strategies and management.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1188/16.cjon.20-03ap
发表时间: 2016-06-01
期刊: Clinical journal of oncology nursing
影响因子: 1.1
作者: [Ercolano E, Grant M, McCorkle R, Tallman NJ, Cobb MD, Wendel C, Krouse R]
通讯作者: Krouse R
Ostomy Telehealth Self-management Training for Cancer Survivors
  • 批准号:
    10435133
  • 项目类别:
  • 资助金额:
    $9.99万
  • 财政年份:
    2021
  • 负责人:
    Robert Scott Krouse
  • 依托单位:
Ostomy Telehealth Self-management Training for Cancer Survivors
  • 批准号:
    10368100
  • 项目类别:
  • 资助金额:
    $62.08万
  • 财政年份:
    2019
  • 负责人:
    Robert Scott Krouse
  • 依托单位:
Ostomy Telehealth Self-management Training for Cancer Survivors
  • 批准号:
    9904567
  • 项目类别:
  • 资助金额:
    $64.65万
  • 财政年份:
    2019
  • 负责人:
    Robert Scott Krouse
  • 依托单位:
Ostomy Telehealth Self-management Training for Cancer Survivors
  • 批准号:
    10620109
  • 项目类别:
  • 资助金额:
    $61.85万
  • 财政年份:
    2019
  • 负责人:
    Robert Scott Krouse
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: